Oxaliplatin News and Research

RSS
Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

Phase III TAS-102 study for metastatic colorectal cancer shows improved survival

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

SLU researchers discover pain pathway and potential way to block it

SLU researchers discover pain pathway and potential way to block it

Amgen presents extended analysis of PEAK study data at ASCO

Amgen presents extended analysis of PEAK study data at ASCO

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Starpharma receives approvals to commence phase 1 human clinical trial for DEP-Docetaxel

Starpharma receives approvals to commence phase 1 human clinical trial for DEP-Docetaxel

European Commission approves update of Erbitux  to treat patients with RAS wild-type mCRC

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Researchers evaluate mangafodipir for relief of oxaliplatin-associated neuropathies

Findings could have important implications for personalized treatment of colon cancer

Findings could have important implications for personalized treatment of colon cancer

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

European Commission approves Stivarga tablets for treatment of patients with mCRC

European Commission approves Stivarga tablets for treatment of patients with mCRC

Aflibercept drug shows minor added benefit for overall survival in colorectal cancer patients

Aflibercept drug shows minor added benefit for overall survival in colorectal cancer patients

Soy peptide injection dramatically reduces colon cancer metastasis in mice

Soy peptide injection dramatically reduces colon cancer metastasis in mice

Adding chemotherapy after surgery for patients with advanced gastric cancer can reduce mortality risk

Adding chemotherapy after surgery for patients with advanced gastric cancer can reduce mortality risk

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Surgery extends life for metastatic colorectal cancer patients

Surgery extends life for metastatic colorectal cancer patients

Combination of cetuximab and chemotherapy improves tumor shrinkage, extends survival

Combination of cetuximab and chemotherapy improves tumor shrinkage, extends survival

Duloxetine drug alleviates pain from chemotherapy

Duloxetine drug alleviates pain from chemotherapy